The potential human trials of COVID-19 vaccine has been initiated by Oxford University in a number of countries in Africa. The vaccine is based on the modification of chimpanzee adenovirus so that it produces a protein in human cells that the COVID-19 also produces.
The African Union’s Africa Centres for Disease Control (CDC) outlined these ongoing COVID-19 trials. They said it is part of the continent’s stride for treatment and vaccination of the virus.
In total, different trials were ongoing in Egypt, Zambia, Nigeria, Tunisia and South Africa. The Africa CDC admitted that comparatively few treatments were taking place on the continent.
The trials are as follows:
- Egypt: There two ongoing vaccine trials ongoing and 13 therapeutics.
- Zambia: Hydroxychloroquine treatment trial is ongoing in Zambia.
- South Africa: Treatment of COVID-19 with Chloroquine, Interferon, Remdesivir is ongoing to test the potency of the drugs.
- Nigeria: One trial is ongoing in Nigeria though therapeutic agents.
- Tunisia: Two trials are ongoing in Tunisia.
It is important to note that all everyone, throughout the world and not just in Africa on COVID-19 vaccine trials is a volunteer. They all between the ages of 18-55, are healthy and have tested negative for COVID-19.
Read Also: How to get COVID-19 test in Nigeria
Follow us on Facebook and Twitter and send us stories on contact@africareinvented.com